San Francisco, United States
Modality.AI, founded in 2018 and headquartered in the United States, is making significant strides in the healthcare industry with its innovative approach to clinical assessments.
The company has developed Tina, a virtual guide that utilizes audiovisual signal processing and AI to conduct self-guided interviews with patients suffering from neurological conditions such as Parkinson's, ALS, and schizophrenia. This technology provides valuable insights into patient functionality and emotional state, offering clinical trial sponsors vital data on how their interventions affect disease progression.
Operating at the intersection of AI, Health Care, Media, and Machine Learning industries, Modality.AI continues to attract attention from investors. The recent Non Equity Assistance investment on 30 November 2023 from Health Engine underscores the company's potential and growing influence in transforming clinical assessments.
